🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
Patients with diabetes have dysfunction of the lining of the arteries which...
Status
Completed
Location
Tameside General Hospital
Start Date
2003-06
Trial ID
NCT00902616
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
To compare the hypothyroid state in patients with thyroid cancer prepared e...
Status
Completed
Location
Centre Hospitalier Universitaire de Sherbrooke
Start Date
2003-09
Trial ID
NCT00223158
Treatments Being Tested
The aims of this proposal include tests of hypotheses of the pathogenetic m...
Status
Unknown
Location
Department of Nuclear Medicine and PET-Centre, Aarhus University Hospital
Start Date
2012-01
Trial ID
NCT02578849
Treatments Being Tested
Phase 1 study of the effects of nitric oxide inhibition with L-NMMA in pati...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00344916
Treatments Being Tested
This is a clinical intervention pilot/feasibility study of PKU carriers (ca...
Status
Completed
Location
University of Guelph
Start Date
2023-07-01
Trial ID
NCT05958784
Treatments Being Tested
The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Status
Unknown
Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Start Date
2019-02-15
Trial ID
NCT03487016
Treatments Being Tested
This pilot clinical trial studies the side effects and best dose of ruxolit...
Status
Completed
Location
City of Hope Medical Center
Start Date
2016-11-13
Trial ID
NCT02917096
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024